Wang Xinyue, Wang Ning, Gao Teng, Zhang Yunfan, Fu Zhao, Zhao Yilu, Huang Yujingwen, Zheng Xiangyu, Gao Xuping, Lu Lin, Yang Li
National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, China.
Department of Medicine, Peking University, Beijing, China.
Gut Microbes. 2025 Dec;17(1):2537755. doi: 10.1080/19490976.2025.2537755. Epub 2025 Jul 27.
Previous evidence links gut microbiota to attention-deficit/hyperactivity disorder (ADHD) through the gut-brain axis. However, the specific microbiota contributing to symptoms remain unclear. To characterize the gut microbial profile related to different symptoms and explore the mediation mechanism between microbiota alterations and the core ADHD symptoms, we conducted shotgun metagenomic sequencing and fecal metabolomics analysis on 94 ADHD patients and 94 age- and gender-matched controls. Microbial characteristics of three subgroups exhibiting different ADHD core symptom presentations were analyzed. We developed a metabolic model and conducted causal mediation analyses to examine how metabolites connect the microbiota to the symptoms. Fecal microbiota transplantation in mice was employed to validate the findings. The redundancy analysis identified ADHD symptoms as environmental gradients and explained the changes in beta diversity (F = 1.345, pFDR = 0.015). Greater gut microbial alterations were observed in combined presentations (ADHD-C). Several beneficial bacteria involved in short-chain fatty acid synthesis were found to be downregulated, with Lactobacillus sanfranciscensis notably linked to all three core symptoms (p.adj = 1.04E-13; p.adj = 5.07E-07; p.adj = 2.61E-05). Various taxa, functional pathways, and metabolites associated with specific ADHD symptom domains were identified. Imidazoleacetic acid partially mediated the effects between Lactobacillus sanfranciscensis and inattention (p = 0.012). In mice subjected to feces from ADHD patients with a low abundance of Lactobacillus sanfranciscensis, treatment with this strain greatly improved both hyperactivity (t = 2.665, p = 0.0237) and inattention (t = 2.389, p = 0.0380), while acetate supplementation only alleviated inattention (t = 2.362, p = 0.0398). Our findings suggest that different ADHD symptoms were related to common and different gut microbiota and metabolites. Fecal microbiota transplantation in mice validated the hypothesis that gut microbial composition affects ADHD symptoms through metabolic alterations. This study provides more insight into the mechanisms underlying metabolic disturbances in ADHD and elucidates the role of gut microbiota in these processes.
先前的证据通过肠-脑轴将肠道微生物群与注意力缺陷多动障碍(ADHD)联系起来。然而,导致症状的具体微生物群仍不清楚。为了描述与不同症状相关的肠道微生物特征,并探索微生物群改变与ADHD核心症状之间的中介机制,我们对94名ADHD患者和94名年龄及性别匹配的对照进行了鸟枪法宏基因组测序和粪便代谢组学分析。分析了表现出不同ADHD核心症状表现的三个亚组的微生物特征。我们建立了一个代谢模型并进行了因果中介分析,以研究代谢物如何将微生物群与症状联系起来。采用小鼠粪便微生物群移植来验证研究结果。冗余分析将ADHD症状确定为环境梯度,并解释了β多样性的变化(F = 1.345,pFDR = 0.015)。在综合表现型(ADHD-C)中观察到更大的肠道微生物改变。发现几种参与短链脂肪酸合成的有益细菌下调,其中旧金山乳杆菌与所有三种核心症状显著相关(p.adj = 1.04E - 13;p.adj = 5.07E - 07;p.adj = 2.61E - 05)。确定了与特定ADHD症状领域相关的各种分类群、功能途径和代谢物。咪唑乙酸部分介导了旧金山乳杆菌与注意力不集中之间的作用(p = 0.012)。在接受旧金山乳杆菌丰度低的ADHD患者粪便的小鼠中,用该菌株治疗可显著改善多动(t = 2.665,p = 0.0237)和注意力不集中(t = 2.389,p = 0.0380),而补充乙酸盐仅缓解了注意力不集中(t = 2.362,p = 0.0398)。我们的研究结果表明,不同的ADHD症状与常见和不同的肠道微生物群及代谢物有关。小鼠粪便微生物群移植验证了肠道微生物组成通过代谢改变影响ADHD症状的假设。本研究为ADHD代谢紊乱的潜在机制提供了更多见解,并阐明了肠道微生物群在这些过程中的作用。